AXSM20261218C350
AXSM Dec 18 2026 350.00 Call (AXSM261218C00350000)
option OPRA

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.